Results 1 to 10 of about 40,030,937 (26)

Pharmacokinetics of dipeptide mimetic BDNF GSB-106 in rats [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2019
Pharmacokinetics of the GSB-106 in variety of administration ways in rats was studied. After single oral administration the test substance was determined for 4 h in the blood plasma. Half-life was 0.65 h.
V. P. Zherdev   +7 more
doaj   +2 more sources

The study of the acute and chronic toxicity dipeptide mimetic of brain-derived neurotrophic factor GSB-106 finished dosage form [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2019
Resume. The study of acute and chronic toxicity of the finished dosage form (SFF) GSB-106, the active substance of which is the substituted dimeric peptide, hexamethylenediamine bis (N-monosuccinyl-L-seryl-L-lysine), which has antidepressant and ...
S. V. Alekseeva   +9 more
doaj   +2 more sources

Comparison of neuroprotective properties of the dipeptide mimetics of the 1st, 2nd and 4th loops of the brain-derived neurotrophic factor on the model oxidative stress in vitro [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2019
Resume. The purpose of this study was to compare neuroprotective properties of the dimeric dipeptide mimetics of the 1st, 2nd and 4th Loops of BDNF - GSB-214 (heptamethylenediamide bis-monosuccinyl-methionyl-serine), GTS-201 (hexamethylenediamide bis ...
I. O. Logvinov   +5 more
doaj   +2 more sources

Evaluation of proliferative activity of the dipeptide mimetics of the 1st, 2nd and 4th loops of the brain-derived neurotrophic factor in vitro

open access: yesФармакокинетика и Фармакодинамика
The purpose of this work was to study the effect of dimeric dipeptide mimetics of the 1st, 2nd and 4th loops of BDNF – GSB-214 (heptamethylenediamide bis-monosuccinyl-methionyl-serine), GTS-201 (hexamethylenediamide bis-hexanoyl-seryl-lysine) and GSB-106
I. O. Logvinov   +2 more
doaj   +1 more source

Effect of the dipeptide BDNF mimetic (compound GSB-106) on reflex development and monoamine levels in Wistar rats with an experimental autism spectrum disorder

open access: yesФармакокинетика и Фармакодинамика
Autism spectrum disorder (ASD) is a neurodevelopmental condition accompanied by alterations in serotonergic, dopaminergic, and noradrenergic systems, as well as delays in early psychomotor and sensorimotor development. One possible approach to correcting
E. V. Savinkova   +4 more
doaj   +1 more source

A study of neuroprotective effect stereospecificity of dipeptide mimetic of the Brain-derived neurotrophic factor GSB-106 on the model oxidative stress in the culture hippocampal cell line HT-22

open access: yesФармакокинетика и Фармакодинамика, 2017
In the present work, the neuroprotective effect stereospecificity of dimeric dipeptide mimetic of the 4th loop of BDNF-GSB-106 is studied. Activity of its diastereomers GT-106DL (hexamethylenediamide bis-monosuccinyl-D-seryl-L-lysine) and GT-106LD ...
I. O. Logvinov   +3 more
doaj  

Исследование взаимодействия дипептидного миметика нейротрофина BDNF ГСБ-106 с тирозинкиназным рецептором TrkB с помощью технологии поверхностного плазмонного резонанса [PDF]

open access: yes, 2023
The interaction of the neurotrophin BDNF dipeptide mimetic, compound GSB-106, with the tyrosine kinase TrkB receptor specific for the fullsized neurotrophin was studied using surface plasmon resonance.
P. Yu. Povarnina   +9 more
core   +1 more source

Миметик мозгового нейротрофического фактора ГСБ-106 оказывает нейропротекторные и нейрорегенеративные эффекты в условиях экспериментального ишемического инсульта [PDF]

open access: yes, 2022
   Background. A dimeric dipeptide mimetic of the brain-derived neurotrophic factor loop 4, bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide (GSB-106), which activates TrkB, PI3K/AKT, MAPK/ERK and PLC-γ1 was created at the V. V. Zakusov Research
P. Yu. Povarnina   +7 more
core   +1 more source

Антидепрессивные свойства дипептидного миметика мозгового нейротрофического фактора ГСБ-106 в тесте Порсолта при внутрибрюшинном субхроническом и хроническом введении мышам [PDF]

open access: yes, 2020
The present work was to study the GSB-106 effect on the immobility behavior of mice Balb/c in the Porsolt test. GSB-106 was administered sub-chronically and chronically intraperitoneal in dose 1 mg/kg.
С. Б. Середенин   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy